Healthcare Industry News: mobile C-arm
News Release - February 18, 2019
Philips launches Zenition mobile C-arm platform for enhanced operating room performance and workflow efficiencyMajor advances pioneered on the Philips Azurion image-guided therapy platform now brought to mobile C-arm systems
New C-arm platform adapts to the needs of a range of surgical specialties to optimize operating room utilization
AMSTERDAM, Feb. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Zenition, its new mobile C-arm imaging platform. mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including orthopedic, trauma and vascular procedures. The Zenition mobile C-arm platform brings together innovations in image capture, image processing, ease-of-use and versatility pioneered on Philips' highly successful Azurion platform. Zenition allows hospitals to maximize OR performance, enhance their clinical capabilities, and offer their staff an outstanding user experience. Zenition will be introduced in the U.S., Germany, Austria and Switzerland in the first half of 2019, and will subsequently be rolled out in further markets.
The scope and complexity of surgical interventions – especially in the rapidly growing area of image-guided minimally invasive surgery – continues to increase, as does the number of patients requiring treatment. In order to treat more patients at a lower cost, hospitals require a versatile fleet of C-arms with varying capabilities that easily adapt to the needs of different types of surgery and different operators. Zenition mobile C-arms are easy to move between operating rooms, simple to position around the patient and intuitive to operate.
"The Philips Zenition is a user-friendly system that's intuitive to use for both surgeons and nursing staff," said Nikolaos Bonaros, Associate Professor of Cardiac Surgery at the Medical University of Innsbruck, Austria. "Its simplified workflow means that we can convert a room from a conventional OR to a high-quality interventional room more quickly. At the same time the system provides high image quality at the level required for hybrid OR procedures."
"As patient numbers rise and procedures become more complex, equipment up-time, utilization and usability become ever more important," said Ronald Tabaksblat, Business Leader for Image Guided Therapy Systems at Philips. "Our new harmonized Zenition mobile C-arm platform offers the proven performance and ease of use needed for surgical teams to work with confidence and precision, now and in the future."
Zenition: intuitive usability and enhanced operational efficiency
Philips Zenition supports increased OR performance across the healthcare facility. The platform's tablet-like user interface and simple 'Unify' workflow mean that once an operator has learned to use one system on the platform, it is easy for them to operate them all. The systems make point-and-shoot image capture fast and intuitive during any interventional or surgical procedure. Zenition's compact design, Position Memory feature  and BodySmart software, which captures fast and consistent images even at the edge of the image intensifier or flat detector, reduce the need for C-arm repositioning by 45% .
For crisp high-quality image viewing, Zenition C-arm systems incorporate the same image processing algorithms used on the company's Azurion platform, offering high-definition visualization of patient anatomies and a greater viewing area. Image quality is assured by features such as Philips' MetalSmart software, which automatically adjusts the contrast and brightness of images to improve image quality when metal objects such as implants are present in the field of view – a feature that makes Zenition systems especially useful in orthopedics.
The Philips Zenition platform is designed for the future, allowing for longer clinical relevance of the systems. With two different detector and image intensifier options and the ability to subscribe to Philips' Technology Maximizer program, Zenition offers users the latest software and hardware technology releases for a fraction of the cost of purchasing them individually.
Zenition is the latest innovation in Philips' unique portfolio of systems, smart devices, software and services in image-guided therapy, which combine to provide healthcare providers with sophisticated, procedure-oriented solutions.
Philips' Zenition C-arms are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA). They will be showcased at the 2019 European Congress of Radiology (ECR) Exhibition (February 28 – March 3, 2019, Vienna, Austria) on Booth 402, Hall X4. Follow @PhilipsLiveFrom for live #ECR2019 updates.
 Only available on Zenition 70.
 Results obtained during user tests performed in November 2013 by Use-Lab GmbH, an independent company. The tests involved 30 USA based clinicians (15 physicians teamed up with 15 nurses or X-ray technicians), who performed simulated procedures in a simulated OR environment. None of them had worked with a Philips C-arm or with each other before.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Source: Royal Philips
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.